February 21, 2025

FDA Approves First Companion Diagnostic to Identify Patients With Metastatic Breast Cancer Eligible for T-DXd

The FDA has approved a label expansion for the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may be e...

The ASCO Post

February 21, 2025

Experimental Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer

The BRAF inhibitor encorafenib plus the monoclonal antibody cetuximab combined with mFOLFOX (modified folinic acid, fluorouracil, and oxaliplatin) significantly improved overall response in BRAF V600E...

The ASCO Post

February 21, 2025

A Measured Response

Is bead-based multiplexing the future of immune response measurement?

The Pathologist

February 20, 2025

18-Year Neuroblastoma Remission in a Patient After GD2 CAR T-Cell Therapy

"She has never required any other therapy and is likely the longest-surviving patient with cancer who received [CAR T-cell] therapy."

Conexiant

February 19, 2025

Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis?

A 62-year-old female developed fixed drug eruption following semaglutide administration, highlighting the importance of recognizing unusual dermatologic reactions during treatment with glucagon-like peptide-1 receptor agonists.

Conexiant

February 18, 2025

AAP Guide Targets Early Biliary Atresia

New AAP clinical report outlines a three-step screening strategy for primary care providers to identify biliary atresia in infants by 2-4 weeks of life, potentially reducing the need for liver transplants.

Conexiant

February 18, 2025

Does a New Blood-Based Screening Test Accurately Detect Colorectal Cancer Risk?

Evaluation of the clinical performance of an investigational blood-based colorectal cancer screening test showed the tool accurately detected colorectal cancer risk in adults aged 45 years and older w...

The ASCO Post

February 17, 2025

Researchers Respond to NIH Funding Cuts

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

The Pathologist

February 17, 2025

Skin Metabolism and Exudation Limit Tattoo Ink Absorption, Study Finds

Researchers examined systemic absorption, metabolism, and excretion of tattoo ink tracers, providing evidence for a cutaneous first-pass effect and measuring systemic exposure levels.

Conexiant